EPIRUBICIN HYDROCHLORIDE

pro_cas
pro_cdbregno
CCD00180570
pro_formula
C27 H29 N O11 . Cl H
pro_molWeight
579.983

basic_info

Product_Name: EPIRUBICIN HYDROCHLORIDE
EnglishSynonyms: EPIRUBICIN EBEWE ; ELLENCE HYDROCHLORIDE ; EPIADRIAMYCIN HYDROCHLORIDE ; ELLENCE ; FARMORUBICIN ; (8S,10S)-10-[(3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-ARABINO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-5,12-NAPHTHACENEDIONE HYDROCHLORIDE ; FARMORUBICIN HYDROCHLORIDE ; (8S-CIS)-4'-EPIDOXORUBICIN HYDROCHLORIDE ; 4'-EPIDOXORUBICIN, HCL ; EPIDOXORUBICIN HYDROCHLORIDE ; EPIRUBICIN HYDROCHLORIDE ; 4'-EPIDOXORUBICIN ; EPIRUBICIN HCL ; 4'-EPIDOXORUBICIN HYDROCHLORIDE ; PHARMORUBICIN ; 4'-EPI-ADRIAMYCIN HYDROCHLORIDE ; PHARMORUBICIN HYDROCHLORIDE ; (1S,3S)-3-GLYCOLOYL-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1,2,3,4,6,11-HEXAHYDRO-1-TETRACENYL 3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-ARABINO-H
pro_mdlNumber: MFCD00941448
pro_acceptors: 12
pro_donors: 6
pro_smile: C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O.Cl
InChi: InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22-,27-;/m0./s1
InChiKey: InChIKey=MWWSFMDVAYGXBV-FGBSZODSSA-N

property

Comments: BIOCHEM/PHYSIOL ACTIONS: CELL-PERMEABLE ANTHRACYCLINE ANTITUMOR ANTIBIOTIC. ANTINEOPLASTIC. A STEREOISOMER OF DOXORUBICIN THAT EXHIBITS REDUCED CARDIOTOXICITY. ITS ANTITUMOR ACTIONS ARE MEDIATED BY TARGETING TOPOISOMERASE II
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

secure_info

* If the product has intellectual property rights, a license granted is must or contact us.